Melanoma Research Reagents | BRAF, PD-1, CTLA-4 Antibodies

Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+

Options

Confirm

Product types

0 selected

Antibodies (298)

Stable Cell Lines (1)

Assay Kit (419)

Biosimilars (1)

Proteins (75)

Research Biosimilar (157)
Expression system

0 selected

HEK293T (1)

Mammalian Cells (185)

E. coli (35)
Target

0 selected

FLT1/VEGFR1 & CD274/PD-L1 (1)

RBD (E484K) (1)

Nivolumab (3)

Atezolizumab (3)

Sotrovimab (1)

Retatrutide (1)

gD/Envelope glycoprotein D (1)

Utomilumab (1)

A29L (6)

EGFR & CD3E & PD-L1 & 4-1BB (1)

B6R/SL-159 (1)

Pogalizumab (1)

Bimekizumab (1)

Guselkumab (3)

Amatuximab (1)

CD274/PD-L1 & VEGFA (1)

NP/Nucleocapsid (5)

dsDNA (1)

Belantamab (1)

Tiragolumab (2)

Obiltoxaximab (1)

CD19 & PD-L1 & CD3E & CD137 (1)

Lupartumab (1)

Pertuzumab (3)

TFF3 (1)

Anifrolumab (1)

Camidanlumab (1)

Varisacumab (1)

Tesidolumab (1)

BSA (1)

Sirukumab (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

BRAF/B-Raf (5)

TYR (1)

Abatacept (1)

Lexatumumab (1)

dsRNA (1)

Ipilimumab (2)

CD274/PD-L1 & CD47/MER6 (1)

gp100 peptide-HLA Complex (1)

Golimumab (3)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

CD223/LAG3 (41)

CD152/CTLA4 & CD134/OX40 (1)

RBD (Kappa) (1)

Ascrinvacumab (1)

Pembrolizumab (3)

Avelumab (3)

CD152/CTLA4 (86)

Casirivimab (1)

Daratumumab (3)

β-D-Glucan (1)

gC/Envelope glycoprotein C (1)

Tezepelumab (1)

IL6 (1)

SARS-CoV-2 Neutralization Antibody (3)

Tavolimab (1)

TIGIT & CD274/PD-L1 (1)

Ixekizumab (1)

Suvizumab (1)

RBD (Omicron/BA.4/BA.5) (1)

Cusatuzumab (1)

Anetumab (1)

Blosozumab (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

Varlilumab (1)

Glycoprotein (5)

Teclistamab (1)

Sarilumab (2)

Vofatamab (1)

Trastuzumab (2)

PD-L1 & TGF-Beta (1)

Obinutuzumab (2)

PD-L1 / VEGF-A (1)

Daclizumab (1)

Emibetuzumab (1)

Protein A (1)

Ziltivekimab (1)

Carlumab (1)

Indatuximab (1)

Tigatuzumab (1)

ATP7B (1)

S100A14 (1)

Lenzilumab (1)

Semorinemab (1)

Tremelimumab (1)

CD274/PD-L1 & CD134/OX40 (1)

T3E (1)

S100A5 (4)

Cixutumumab (1)

Andecaliximab (1)

Enoblituzumab (1)

TYRP1 (3)

Gremubamab (1)

RBD (Delta Plus) (1)

Sintilimab (1)

Durvalumab (3)

Imdevimab (1)

S100A4 (3)

gC/UL44 (1)

Magrolimab (1)

RBD (Omicron/BA.5) (3)

Lirilumab (1)

Remtolumab (1)

Vorsetuzumab (1)

DCT (2)

Romosozumab (1)

CD274/PD-L1 & CD137/TNFRSF9 (1)

Romiplostim (2)

M/Matrix protein (2)

Rituximab (1)

Depatuxizumab (1)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Zanidatamab (1)

Afutuzumab (1)

Icrucumab (1)

CD366/HAVCR2/TIM-3 (4)

PDL1 (6)

Crizanlizumab (1)

TRP-1 & CD3e (1)

Tanezumab (1)

Human β Amyloid (1-42) (1)

S100A6 (1)

LAG-3 & PD-1 (1)

S100A10 (4)

TPP15 (1)

Namilumab (1)

Tilavonemab (1)

CTLA4 & PD1 (2)

Zalifrelimab (1)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Infliximab (2)

Dalotuzumab (1)

Tirzepatide (2)

Pasotuxizumab (1)

Mirzotamab (1)

M1R (5)

Semaglutide (2)

Cinpanemab (1)

Tislelizumab (1)

Pacmilimab (1)

CD274/PD-L1 & CD152/CTLA4 (1)

CD223/LAG3 & CD279/PD-1 (4)

Ifabotuzumab (1)

Siltuximab (3)

gD/US6 (1)

Elezanumab (1)

Etanercept (3)

NP/Nucleoprotein (3)

CD20/MS4A1 (3)

Secukinumab (2)

Foravirumab (1)

Elotuzumab (1)

Ontamalimab (1)

Eculizumab (3)

Talacotuzumab (1)

Figitumumab (1)

Farletuzumab (1)

S100A1 (2)

SOX10 (3)

S100A12 (1)

Oxelumab (1)

Losatuxizumab (1)

Spike glycoprotein (RBD) (1)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

Epcoritamab (1)

Fluorescein & CD274/PD-L1 (1)

Ibalizumab (1)

S100a15a (1)

Tocilizumab (3)

Inclacumab (1)

S100P (1)

Human β Amyloid (1-40) (1)

Cergutuzumab (1)

KITLG/SCF (1)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Lorvotuzumab (1)

Lintuzumab (1)

TPP17 (1)

Otilimab (1)

Zagotenemab (1)

IDO1 (2)

CD274/PD-L1 & CD28 (1)

T-cell surface glycoprotein CD3 epsilon chain (1)

Aflibercept (1)

Vibecotamab (1)

Glycoprotein G (2)

GP/Envelope glycoprotein (4)

Rosopatamab (2)

TYR/Tyrosinase (2)

Omburtamab (1)

Evolocumab (1)

CD366/TIM-3 & CD274/PD-L1 (1)

Toripalimab (1)

CD279/PD-1 & CD152/CTLA4 (4)

Denosumab (3)

US8/gE (1)

Sibrotuzumab (1)

HLA-A2-peptide (TDQVPFSV) Complex (1)

RBD (6)

RBD (Omicron/JN.1) (1)

Codrituzumab (1)

Mazdutide (2)

NRAS (2)

Rafivirumab (1)

RBD (WT) (1)

CD274/PD-L1 & TGFBR2 (1)

Meplazumab (1)

Mirikizumab (2)

S100A16 (1)

Canakinumab (1)

MLANA (4)

Ganitumab (1)

Mirvetuximab (1)

Necitumumab (1)

Zenocutuzumab (1)

CD274/PD-L1/B7-H1 (5)

Glofitamab (1)

Ieramilimab (1)

S100A13 (1)

Tregalizumab (1)

TRP-1 & CD47/MER6 (1)

Adalimumab (3)

S100A2 (1)

TAU pT181 (1)

Labetuzumab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Faricimab (1)

TPP47 (1)

TDP2 (1)

Asp f 1/mitF (1)

MITF (1)

CD223 (1)

Edrecolomab (1)

S100A11 (2)

gG/US4 (2)

PMEL17/ME20M (9)

Tarextumab (1)

H3L (3)

Alirocumab (1)

CD137/4-1BB & CD274/PD-L1 (3)

CD79B (2)

S100A8 (3)

Nirsevimab (1)

CD223/LAG3 & CD152/CTLA4 (1)

Cetuximab (3)

Letolizumab (1)

Imlifidase (5)

Spike glycoprotein E2 (2)

Enfortumab (1)

RBD (Delta) (3)

Dupilumab (3)

RBD (Omicron/KP.2) (1)

Tibulizumab (1)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

RBD (Alpha) (1)

p-Tyr (1)

Glembatumumab (1)

VSIR/VISTA & CD274/PD-L1 (1)

Gevokizumab (1)

Teprotumumab (1)

VASH2/Vasohibin-2 (1)

Bevacizumab (3)

Panitumumab (3)

EPO/Erythropoietin (1)

cAMP (1)

Ibritumomab (1)

Benufutamab (1)

Zanolimumab (1)

Lacnotuzumab (1)

Olaratumab (1)

TRP-1 & CD134/OX40 (1)

TAU pT217 (1)

Tisotumab (1)

Oleclumab (1)

Nesvacumab (1)

G/Major surface glycoprotein G (1)

Milatuzumab (1)

Befovacimab (1)

Balstilimab (1)

Dilpacimab (1)

Natalizumab (2)

Exenatide acetate (2)

gB/Envelope glycoprotein B (1)

Omalizumab (2)

Frovocimab (1)

E8L (5)

CD274/PD-L1 & CD279/PD-1 (1)

Palivizumab (3)

CD47/MER6 & CD274/PD-L1 (2)

sCD14 (1)

Simlukafusp Alfa (1)

Spike glycoprotein (10)

CD340/ERBB2 (1)

Astegolimab (1)

LAG3 & PD-1 (1)

Vunakizumab (1)

HLA-A2-peptide (YLEPGPVT) Complex (4)

Tosatoxumab (1)

CD152/CTLA4 & CD279/PD-1 (1)

RBD (Beta) (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

Alacizumab (1)

PD-L1 & VEGF (1)

Concizumab (1)

Rolinsatamab (1)

CD278/ICOS (1)

Brolucizumab (1)

Serclutamab (1)

S100B (9)

Clazakizumab (1)

S100A9 (4)

Mosunetuzumab (1)

Mavezelimab (1)

CD80/B7-1 (20)

Conatumumab (1)

Tovetumab (1)

CD279/PD-1 & CD274/PD-L1 (1)

Certolizumab (2)

Calprotectin (S100A8/9) (3)

Cabiralizumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

CD152/CTLA4 & CD274/PD-L1 (1)

Vanucizumab (1)

N/Nucleoprotein (1)

Ramucirumab (1)

Cetrelimab (1)

Navicixizumab (1)

Bimagrumab (1)

gE/Envelope glycoprotein E (1)

CD175/Tn (10)

Urelumab (1)

Lodelcizumab (1)

A35R (5)

CD366/TIM-3 & CD279/PD-1 (2)

Ustekinumab (3)

Ivuxolimab (1)

Afasevikumab (1)

Suptavumab (1)

F/Fusion glycoprotein F0 (5)

Itolizumab (1)

Ianalumab (1)

CD274/PD-L1 & SLT-Ia (1)

Spike Protein (Trimer) (2)

Iscalimab (1)

IL1RL1/ST2 (1)

mitF/aspF1 (1)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

RBD (Gamma) (1)

CD80&IL2 (1)

Disitamab (1)

Marstacimab (1)

CD80/B7-1 & CD86/B7-2 (2)

Basiliximab (1)

Apamistamab (1)

CD117/KIT (24)

Ranibizumab (3)

CD274/PD-L1 (81)

CD366/TIM-3 (34)

cGMP (1)

Olokizumab (1)

Ocaratuzumab (1)

Favezelimab (1)

CD86/B7-2 (26)

Drozitumab (1)

Spike glycoprotein E1 (2)

Eldelumab (1)

Sacituzumab (1)

PDL1 & VEGF (1)

CD274/PD-L1 & CD3E (1)

CD3E (1)

Emactuzumab (1)

Imalumab (1)

Zampilimab (1)
Species

0 selected

Felis catus (Cat) (9)

Canis lupus familiaris (1)

Cat (1)

Mouse (24)

Rat (1)

Mus musculus (Mouse) (7)

Tupaia chinensis (12)

Canis lupus familiaris (Dog) (8)

Homo sapiens (Human) (7)

Neosartorya fumigata (1)

Human (177)

Dog (3)
Applications

0 selected

in vivo CTLA-4 neutralization (2)

Bioactivity: FACS (1)

Research in vivo (4)

FCM (152)

in vivo intra-tumoral regulatory T cell depletion (2)

Bioactivity: FACS (153)

in vivo blockade (2)

in vivo (2)

SDS-PAGE (75)

Blocking (2)

Functional assay (158)

SPR (4)

Immunogen (75)

IP (2)

FuncS (18)

Research in vivo (158)

in vivo PD-L1 blockade (3)

Bioactivity testing in progress (31)

Neut (1)

IFA (4)

in vitro PD-L1 blockade (3)

ELISA (844)

Inhib (1)

FACS (5)

GICA (2)

IHC-F (3)

IHC (84)

Neutralization (2)

Functional assay (6)

WB (165)

IF (8)
Reactivity

0 selected

Kirsten murine sarcoma virus (1)

Cat (1)

Dog (13)

Chicken (4)

Homo sapiens (Human) (4)

Mouse (81)

Kryptolebias marmoratus (1)

Pig (6)

Macaca mulatta (1)

Pongo abelii (2)

Human (199)

Rat (16)

Tupaia chinensis (4)

Limanda limanda (1)

Carassius auratus (1)

Bos taurus (8)

Mesocricetus auratus (1)

Neosartorya fumigata (1)

Cavia porcellus (1)

Monkey (5)

Broad-Spectrum (1)

Cyprinus carpio (1)

Oryctolagus cuniculus (4)

Monodelphis domestica (1)

B7-H1 / PD-L1 / CD274 (1)

Danio rerio (1)

Callithrix jacchus (1)

Avian retrovirus IC10 (1)

Oryzias latipes (1)

Drosophila grimshawi (1)

Capra hircus (1)

Avian rous-associated virus type 1 (1)

Cynomolgus monkey (1)

Xenopus laevis (1)

Mus musculus (Mouse) (1)

Drosophila willistoni (1)

Coturnix japonica (1)

Rhesus macaque (1)

Bovine (1)
Host species

0 selected

Chimeric (5)

Alpaca (6)

Rabbit (61)

HEK293T (1)

Human (157)

Armenian Hamster (5)

Rat (14)

Humanized (34)

Dog (2)

Mouse (164)
Clonality

0 selected

Monoclonal (398)

Polyclonal (53)
Conjugate

0 selected

PerCP (28)

PE (28)

Unconjugated (301)

FITC (28)

APC (28)